3-cyano-quinoline derivatives with antiproliferative activity

Details for Australian Patent Application No. 2004298784 (hide)

Owner Janssen Pharmaceutica N.V.

Inventors Freyne, Eddy Jean Edgard; Embrechts, Werner Constant Johan; Buijnsters, Peter Jacobus Johannes Antonius; Van Emelen, Kristof; Perera, Timothy Pietro Suren

Agent Shelston IP

Pub. Number AU-B-2004298784

PCT Pub. Number WO2005/058318

Priority PCT/EP03/51059 18.12.03 EP

Filing date 15 December 2004

Wipo publication date 30 June 2005

Acceptance publication date 9 June 2011

International Classifications

C07D 498/08 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms

Event Publications

29 June 2006 PCT application entered the National Phase

  PCT publication WO2005/058318 Priority application(s): WO2005/058318

9 June 2011 Application Accepted

  Published as AU-B-2004298784

6 October 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004298788-Tricyclic imidazopyridines for use as gastric secretion inhibitors

2004298782-Tricyclic 1-[(3-indol-3-yl)carbonyl] piperazine derivatives as cannabinoid CB1 receptor agonists